Natalia Torres
Family · Chicago, ILNPI 1659899755
Payments from drug & device makers
Across 203 payments — averaging $26.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Ardelyx, Inc.$381
- Madrigal Pharmaceuticals$244
- Takeda Pharmaceuticals U.S.A., Inc.$174
- Evoke Pharma, Inc.$167
- plus $506 from 11 others
What the payments were for
- Consulting fees$1,40026%
- Food & beverage$3,89374%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $2,592 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 87 | $1,229 |
| Ardelyx, Inc. | 14 | $381 |
| Madrigal Pharmaceuticals | 5 | $244 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $174 |
| Evoke Pharma, Inc. | 4 | $167 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| Phathom Pharmaceuticals, Inc. | 2 | $76 |
| Braintree Laboratories, Inc. | 4 | $66 |
| Johnson & Johnson | 2 | $61 |
| Gilead | 2 | $53 |
| Merck | 2 | $40 |
| Bristol Myers Squibb | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Echosens North America, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,293 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 122 | $87,136 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 381 | $24,910 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 25 | $3,668 |
| Omeprazole | 207 | $2,311 |
| Minocycline Hcl | 21 | $345 |
| Hydrocortisone | 14 | $304 |
| Metronidazole | 24 | $278 |
| Amoxicillin | 21 | $200 |
| Pantoprazole Sodium | 24 | $177 |
| Metoclopramide Hcl | 23 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $2,592 | $87,136122 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu | $1,229 | $3,66825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.
Other family in Chicago
- Ruth CarricoChicago$582K
- Jamie BroganChicago$282K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Brittony CroasdellChicago$192K
- Stephanie Bradley-MillerChicago$156K
- Elizabeth LegorretaChicago$150K
- Staci GorsonChicago$61K
- Allison MoserChicago$60K
- Darcie McDonaughChicago$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.